Andreas Fouras News Today

The New Criterion's Tim Boreham uncovers the potential of 4D Medical in the USA

Global medtech company 4D Medical, creator of lung function imaging technology, has announced a merger with Imbio, reporting that combining existing technologies will drive respiratory health improvements around the globe.

/PRNewswire/ -- Imbio, Inc. (a portfolio company of Minneapolis-based Invenshure LLC), a provider of medical imaging analysis technologies for chronic lung and...

Street Talk understands the medtech business is set to have its brokers Bell Potter and E&P round up investors at 79¢ per share.

A producer of advanced lung function imaging software, 4D Medical has received U.S Food and Drug Administration (FDA) clearance for its CT-based ventilation product (CT LVAS). The company’s software scans, analyzes CT images providing rich data on regional lung function, enabling radiologists to furnish new levels of quantified, data-based correlation between function and structure to patients' physicians, using existing CT scanning equipment, according to a company statement released No...

/PRNewswire/ -- 4DMedical, the leading producer of advanced lung function imaging software has received FDA clearance for its CT-based ventilation product (CT...

Key Insights 4DMedical will host its Annual General Meeting on 1st of November CEO Andreas Fouras' total compensation...

Bell Potter was offering the shares, which are up 183 per cent year-to-date, at 91¢ apiece,

ASX opens higher following strong finish on Wall Street over the weekend. Earnings season continues with Origin, Judo, Sezzle, Santos featuring.

The ASX 200 opens strongly on Tuesday. Consumer sentiment rallies following RBA rate hike pause. Evergreen Lithium debuts on ASX.